Odyssey Health (ODYY) Shareholder's Equity (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -48.09% |
| Oct 31, 2025 | -2.88% |
| Jul 31, 2025 | -3.76% |
| Apr 30, 2025 | -3.71% |
| Jan 31, 2025 | -2.93% |
| Oct 31, 2024 | -17.72% |
| Jul 31, 2024 | -167.69% |
| Apr 30, 2024 | -9.12% |
| Jan 31, 2024 | 239.43% |
| Oct 31, 2023 | -1.01% |
| Jul 31, 2023 | -5.77% |
| Apr 30, 2023 | -8.45% |
| Jan 31, 2023 | 0.32% |
| Oct 31, 2022 | -15.94% |
| Jul 31, 2022 | -13.82% |
| Apr 30, 2022 | 2.33% |
| Jan 31, 2022 | -39.44% |
| Oct 31, 2021 | -8.25% |
| Jul 31, 2021 | -192.25% |
| Apr 30, 2021 | 6.80% |
| Jan 31, 2021 | -84.73% |
| Oct 31, 2020 | 15.58% |
| Jul 31, 2020 | 46.96% |
| Apr 30, 2020 | -19.75% |
| Jan 31, 2020 | -17.01% |
| Oct 31, 2019 | -47.64% |
| Jul 31, 2019 | 39.40% |
| Apr 30, 2019 | -6.15% |
| Jan 31, 2019 | -3.84% |
| Oct 31, 2018 | -8.48% |
| Jul 31, 2018 | -8.66% |
| Apr 30, 2018 | -442.92% |
| Jan 31, 2018 | 145.50% |
| Oct 31, 2017 | -15.10% |
| Jul 31, 2017 | -9.03% |
| Apr 30, 2017 | -26.23% |
| Jan 31, 2017 | -2.96% |
| Oct 31, 2016 | -21.22% |
| Jul 31, 2016 | -17.74% |
| Apr 30, 2016 | -4.10% |
| Jan 31, 2016 | -8.79% |
| Oct 31, 2015 | -15.79% |